Free tool
FAERS Monitor: Cupric Chloride In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018960 or its brand name (Cupric Chloride In Plastic Container, Cupric Chloride). Reports on generic versions are filed under their own applications.
Reports
748
Serious
502
67% of reports
Hospitalization
224
Death reported
42
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue75
- off label use74
- headache64
- nausea64
- pain61
- diarrhoea60
- drug ineffective53
- weight decreased49
- malaise43
- abdominal pain40
- anaemia37
- dizziness36
- dyspnoea36
- constipation32
- urinary tract infection29
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 6 |
| 2010 | 9 |
| 2011 | 14 |
| 2012 | 13 |
| 2013 | 21 |
| 2014 | 21 |
| 2015 | 32 |
| 2016 | 60 |
| 2017 | 23 |
| 2018 | 46 |
| 2019 | 57 |
| 2020 | 52 |
| 2021 | 65 |
| 2022 | 70 |
| 2023 | 66 |
| 2024 | 64 |
| 2025 | 69 |
| 2026 | 47 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,411 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| anaemiaSignal | 37 | 5.5 | 4.0 | 131 |
| weight decreasedSignal | 49 | 4.9 | 3.8 | 152 |
| abdominal painSignal | 40 | 4.8 | 3.6 | 119 |
| urinary tract infectionSignal | 29 | 4.8 | 3.3 | 84 |
| constipationSignal | 32 | 4.1 | 2.9 | 73 |
| headacheSignal | 64 | 2.9 | 2.3 | 78 |
| painSignal | 61 | 2.8 | 2.2 | 70 |
| malaiseSignal | 43 | 2.8 | 2.1 | 47 |
| fatigueSignal | 75 | 2.7 | 2.2 | 82 |
| diarrhoeaSignal | 60 | 2.6 | 2.1 | 60 |
| off label useSignal | 74 | 2.4 | 1.9 | 60 |
| nauseaSignal | 64 | 2.3 | 1.8 | 46 |
| dizzinessSignal | 36 | 2.0 | 1.5 | 18 |
| dyspnoea | 36 | 1.8 | 1.3 | 12 |
| drug ineffective | 53 | 1.1 | 0.9 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.